352018-90-7

Usage

Uses

Used in Pharmaceutical Synthesis:
ETHYL 1-(4-CYANOPHENYL)-4-PIPERIDINECARBOXYLATE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic chemistry, ETHYL 1-(4-CYANOPHENYL)-4-PIPERIDINECARBOXYLATE is used as a valuable intermediate, facilitating the creation of complex organic molecules and contributing to advancements in chemical research and development.
Used in Scientific Research:
ETHYL 1-(4-CYANOPHENYL)-4-PIPERIDINECARBOXYLATE is employed as a research compound in various scientific studies, particularly in the exploration of its biological activities and potential applications in medicine and other fields.

InChI:InChI=1/C15H18N2O2/c1-2-19-15(18)13-7-9-17(10-8-13)14-5-3-12(11-16)4-6-14/h3-6,13H,2,7-10H2,1H3

Upstream product

• 1126-09-6 4-carbethoxypiperidine 
• 34916-10-4 4-cyanocyclohexanone 
• 1194-02-1 4-fluorobenzonitrile 

Downstream Products

• 162997-21-9 1-(4-cyanophenyl)piperidine-4-carboxylic acid 
• 771583-44-9 C₁₅H₂₂N₂O₂ 

Relevant academic research and scientific papers

Three new isostructural coordination polymers with Cd(II) clusters as the SBU: Synthesis, structural characterization, and luminescence properties

Three new isostructural coordination polymers, {Cd1.33L(Cl) 0.67(H2O)0.67}n (1), {Cd 1.33L(Br)0.67(H2O)0.67}n (2), and {Cd1.33L(I)sub

Electrochemical Cross-Dehydrogenative Aromatization Protocol for the Synthesis of Aromatic Amines

The introduction of amines onto aromatics without metal catalysts and chemical oxidants is synthetically challenging. Herein, we report the first example of an electrochemical cross-dehydrogenative aromatization (ECDA) reaction of saturated cyclohexanones and amines to construct anilines without additional metal catalysts and chemical oxidants. This reaction exhibits a broad scope of cyclohexanones including heterocyclic ketones, affording a variety of aromatic amines with various functionalities, and shows great potential in the synthesis of biologically active compounds.

ANTI-INFECTIVE COMPOUNDS

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

1, 4-DISUBSTITUTED PIPERIDINES AS VASOPRESSIN RECEPTOR VIA ANTAGONISTS

The present invention provides compounds of formula (1) compositions comprising such compounds; the use of such compounds in therapy (such as in the treatment of dysmenorrhoea); and methods of treating patients with such compounds; wherein A and G are as defined herein.

USE OF SUBSTITUTED 2-PHENYLBENZIMIDAZOLES AS MEDICAMENTS

The invention relates to the use of a substituted 2-phenylbenzimidazole of formula (I), where R1, R2, R3, R4, R5 and m have the meanings given in the claims, for the production of a medicament for the treatment or prevention of diseases in which glucagon receptors are implicated and novel compounds of formula (I), where R1 is a group of formula (II).

PIPERAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES

The present invention relates to novel piperidine carbonyl piperazine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.